Preoperative Chemo-radiotherapy (CT-RT) Improves Local Control in T3-T4 Rectal Cancers: Results of the FFCD 9203 Randomized Trial

Reviewer: Chika Madu, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 17 de octubre del 2005

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Short-, Long-Course Therapy Comparable in T3 Rectal Cancer

Sep 27, 2012

No significant differences in rates of local, distant recurrence; overall survival; or late toxicity

ASTRO: New Chemo, Radiation Combo Suggested in Rectal Cancer

Oct 4, 2011

Patients have 88 percent chance of survival at three years with capecitabine, radiation at 50 Gy

Randomized Controlled HCC Screening Trial Not Feasible

Dec 8, 2011

And, US screening every three versus six months does not improve small liver cancer detection rate

From the National Cancer Institute